| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $80 to $77.
Wells Fargo analyst Christian Wetherbee maintains ArcBest (NASDAQ:ARCB) with a Equal-Weight and lowers the price target from...
ARCB shares fell following Q3 2025 results, beating estimates for adjusted earnings and revenue. Operating cash flow was $184.3...
Stifel analyst J. Bruce Chan maintains ArcBest (NASDAQ:ARCB) with a Buy and raises the price target from $81 to $85.
Adhishthana.com analysis reveals why ArcBest Stock's recent slide was written in its charts. With a broken arc on the weekl...
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $85 to $87.
Citigroup analyst Ariel Rosa upgrades ArcBest (NASDAQ:ARCB) from Neutral to Buy and raises the price target from $79 to $89.